- Home
- TORO vs VNRX Comparison
TORO vs VNRX Comparison
Compare TORO & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TORO
- VNRX
- Stock Information
- Founded
- TORO 2022
- VNRX N/A
- Country
- TORO Cyprus
- VNRX United States
- Employees
- TORO N/A
- VNRX N/A
- Industry
- TORO Marine Transportation
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- TORO Consumer Discretionary
- VNRX Health Care
- Exchange
- TORO Nasdaq
- VNRX Nasdaq
- Market Cap
- TORO 67.1M
- VNRX 69.7M
- IPO Year
- TORO N/A
- VNRX N/A
- Fundamental
- Price
- TORO $3.79
- VNRX $0.33
- Analyst Decision
- TORO
- VNRX Strong Buy
- Analyst Count
- TORO 0
- VNRX 4
- Target Price
- TORO N/A
- VNRX $3.17
- AVG Volume (30 Days)
- TORO 47.8K
- VNRX 913.1K
- Earning Date
- TORO 11-14-2025
- VNRX 11-13-2025
- Dividend Yield
- TORO N/A
- VNRX N/A
- EPS Growth
- TORO N/A
- VNRX N/A
- EPS
- TORO 0.01
- VNRX N/A
- Revenue
- TORO $20,143,992.00
- VNRX $1,472,007.00
- Revenue This Year
- TORO N/A
- VNRX $324.32
- Revenue Next Year
- TORO N/A
- VNRX $247.82
- P/E Ratio
- TORO $288.59
- VNRX N/A
- Revenue Growth
- TORO 0.40
- VNRX 14.48
- 52 Week Low
- TORO $1.70
- VNRX $0.31
- 52 Week High
- TORO $4.94
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- TORO 48.89
- VNRX 29.21
- Support Level
- TORO $3.58
- VNRX $0.31
- Resistance Level
- TORO $3.85
- VNRX $0.36
- Average True Range (ATR)
- TORO 0.23
- VNRX 0.04
- MACD
- TORO -0.01
- VNRX -0.00
- Stochastic Oscillator
- TORO 45.57
- VNRX 11.58
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.